Alembic Pharmaceuticals Limited (APLLTD.NS) NSE

903.95

-5.95(-0.65%)

Updated at September 29 01:12PM

Currency In INR

Valuation

Market Cap176.29B
Enterprise Value187.97B
P/E Ratio29.65
PEG Ratio8.69
Price/Sales Ratio2.62
Price/Book Ratio3.44
Enterprise/Revenue2.79
Enterprise/EBITDA17.31

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.09
Operating Margin0.21

Management Effectiveness

Return On Assets0.08
Return On Equity0.12

Income Statement

Revenue66.72B
Revenue/Share346.84
Gross Profit48.79B
EBITDA10.08B
Net Income5.83B
Diluted EPS29.68

Balance Sheet

Total Cash901M
Total Cash/Share4.58
Total Debt12.58B
Total Debt/Equity0.24
Current Ratio1.69
Book Value Per Share263.88

Price History

52-Week Change-24.58
52-Week High1,303.9
52-Week Low725.2
Moving Average 50 Days962.19
Moving Average 200 Days937.51

Statistics

Average Volume369,807
Shares Outstanding196.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.21
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A